Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Cirrhosis × Nadolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hemangioma, Capillary 2 Motor Activity 1 Lymphoma 1 Liver Cirrhosis 1 Leukemia 1 Hemangioma 1 Carcinoma, Hepatocellular 1

Interventions

Ultrasonography 2 tremelimumab 1 lenvatinib 1 hepatitis C immune globulin, human 1 epigallocatechin gallate 1 durvalumab 1 Vitamin B 6 1 Urination 1 Tomography, X-Ray Computed 1 Tidal Volume 1 Rosuvastatin Calcium 1 Propranolol 1 Probiotics 1 Preoperative Exercise 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Population Groups 1 Plasmapheresis 1 Oxaliplatin 1 Nadolol 1 Mebendazole 1 Introns 1 Immunoglobulin G 1 Glutathione 1 Gemcitabine 1 Furosemide 1 Everolimus 1 Ethiodized Oil 1 Ethanol 1 Erlotinib Hydrochloride 1 Digoxin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00567216 2010-06-08

GVO-nadolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡